EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Iopanoic acid in severe thyrotoxicosis: rediscovering an effective therapy

Peter Taylor iD, Nadia Schoenmakers, Leonidas Duntas, Anna Scholz, Fizzah Iqbal, Lynette James, Colin Dayan, Carla Moran, Kristien Boelaert iD

The Journal of Clinical Endocrinology & Metabolism · 14.10.2026

DOI: 10.1210/clinem/dgag421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 14.10.2026. Verfasst von Peter Taylor und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Immunotherapy, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingha…. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe thyrotoxicosis remains a high-risk endocrine emergency, particularly in thyroid storm and amiodarone-induced thyrotoxicosis (AIT), where morbidity and mortality remain substantial despite modern intensive care. Rapid reduction of circulating triiodothyronine (T3) is central to stabilization, yet conventional therapies are often slow, unpredictable, or ineffective, particularly in iodine-replete states such as AIT. Summary We reviewed mechanistic, pharmacokinetic, and clinical evidence for iopanoic acid, a potent inhibitor of type I and type II 5′-deiodinase that produces rapid, reversible suppression of peripheral thyroxine (T4) to T3 conversion, alongside comparative rescue strategies including Lugol iodine, perchlorate, lithium, cholestyramine, and therapeutic plasma exchange. Across early clinical studies and a contemporary tertiary-center case series, short-course iopanoic acid consistently produced large, rapid reductions in serum T3, typically within 24 to 48 hours, with parallel clinical improvement. In a recent series of 12 patients with treatment-resistant thyrotoxicosis, mean free T3 fell by approximately 55%, normalizing within a median of 2 days and enabling progression to definitive surgery in most cases. Reported use extends beyond thyroid storm to urgent preoperative preparation of uncontrolled hyperthyroidism, AIT, and destructive thyroiditis. Adverse effects are uncommon and generally mild, and withdrawal from routine clinical use reflects the obsolescence of oral cholecystography rather than safety concerns.

Conclusion

Iopanoic acid offers safe, rapid, and predictable T3 reduction as short-course rescue or bridging therapy in thyroid storm and refractory, iodine-unresponsive AIT, where it can be lifesaving. It is not recommended for straightforward thyrotoxicosis. We synthesize the evidence into a pragmatic, protocol-based framework and argue that reliable, appropriately governed sourcing is now the principal barrier to its use.

Schlagwörter

Stichwörter der Autor:innen

Iopanoic acidamiodarone-induced thyrotoxicosisdrug repurposingendocrine emergenciesthyroid stormtriiodothyronine

Autor:innen und Institutionen

  • Department of Immunology and Immunotherapy, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, United Kingdom.
  • Department of Endocrinology, University Hospital of Wales, Cardiff, United Kingdom.
  • School of Medical Sciences, Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK.
  • Evgenideion Hospital, Unit of Endocrinology, Diabetes and Metabolism, Thyroid Section, National and Kapodistrian University of Athens, Athens, Greece.
  • Cardiff and Vale University Health Board, Cardiff, United Kingdom.
  • Cardiff University, School of Pharmacy & Pharmaceutical Sciences, Cardiff, United Kingdom.

ORCID-Profile: Peter Taylor, Kristien Boelaert

Zitieren

APA

Taylor, P., Schoenmakers, N., Duntas, L., Scholz, A., Iqbal, F., James, L., Dayan, C., Moran, C., & Boelaert, K. (2026). Iopanoic acid in severe thyrotoxicosis: rediscovering an effective therapy. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag421

Vancouver

Taylor P, Schoenmakers N, Duntas L, Scholz A, Iqbal F, James L, et al. Iopanoic acid in severe thyrotoxicosis: rediscovering an effective therapy. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag421

BibTeX
@article{Taylor2026,
  author = {Taylor, Peter and Schoenmakers, Nadia and Duntas, Leonidas and Scholz, Anna and Iqbal, Fizzah and James, Lynette and Dayan, Colin and Moran, Carla and Boelaert, Kristien},
  title = {Iopanoic acid in severe thyrotoxicosis: rediscovering an effective therapy},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgag421}
}
Kostenlos starten →